Search

Objective: To technically review and explore long-term follow-up results of aqueductoplasty and stenting under flexible neuroendoscopy in infantile obstructive hydrocephalus., Methods: The clinical data, surgical techniques, and long-term effects in 14 infants with obstructive hydrocephalus treated by flexible neuroendoscopic aqueductoplasty and stenting between 2008 and 2010 were analyzed retrospectively., Results: The 14 infants had a mean age of 5.71 ± 3.10 months (range, 2-11 months) and a mean duration of follow-up of 62.64 ± 34.52 months (range, 9-121 months). Subdural effusion was observed in 4 infants (28.6%) after surgery. There were no deaths or serious complications related to intracranial stent placement. Three infants (21.4%) failed, 2 due to proximal aqueduct occlusion from a short stent length and 1 due to intraluminal ependymal adhesion obstruction. One case was abandoned when a second surgical adjustment stent was unsuccessful, and the other 2 cases went to shunt surgery., Conclusions: Aqueductoplasty with stenting is a feasible and safe surgical procedure for treating infants with midbrain aqueduct stenosis or occlusion. However, the optimal stent material and definitive outcomes after this procedure require additional long-term follow-up studies in large numbers of infants., (Copyright © 2019 Elsevier Inc. All rights reserved.)

Introduction: Aqueductoplasty as well as aqueductal stenting is an accepted therapy option in short-segment aqueductal stenosis and isolated fourth ventricle. Over the years, different techniques with only slight modifications by using a conventional neuroendoscope with a working sheath to introduce different instruments have been presented. In summary, the use of Fogarty balloon catheters or flexible endoscopes to pass the narrowed aqueduct is recommended., Methods: This technical report describes a substantially new technique for this purpose. Six patients underwent aqueductal stenting with a new intracatheter endoscope., Results: Aqueductal stenting was possible in 4 out of 6 cases. No complications occurred. Handling of this new technique was good and easy without a prolonged learning curve. All four stents did work appropriately, and the procedure was considered to be successful. Of the two failures, the technique was abandoned and endoscopic third ventriculostomy (ETV) was performed in one. In the other case, suboccipital shunting was done., Conclusion: This technical report describes a substantially new technique for aqueductal stenting. The combination of an intracatheter miniature endoscope and a prepared ventricular catheter enables careful and elegant aqueductal stenting. Large or flexible endoscopes, balloons, or special instruments to place a stent have become completely obsolete in selected cases.

Objective: Complicated hydrocephalus, such as trapped fourth ventricle, is challenging. Aqueduct stent placement is a possible alternative to the conventional multiple shunts approach. This article discusses the indications, techniques, and clinical experiences of aqueduct stent placement., Methods: We retrospectively analyzed a series of 10 consecutive patients with hydrocephalus and had aqueduct stent placement between February 2009 and May 2014. The clinical and imaging data were collected and the indications, technique, and clinical experience of aqueduct stent placement were analyzed and discussed., Results: Among the 10 patients (mean age, 38 years; range, 5 months-69 years), 8 patients harbored an obstructive hydrocephalus caused by aqueductal obstruction. The underlying pathology consisted of intraventricular tumor in 3 patients, intraventricular cysticercosis in 2, and membranous or inflammatory obstruction in 3 patients. Two patients presented with trapped fourth ventricle, which resulted from Dandy-Walker malformation and shunt placement, respectively. Aqueduct stents were placed endoscopically in 8 patients, whereas the other 2 were placed microscopically. There were no deaths due to aqueduct stent placement. Postoperatively, all of the patients showed improvement or resolution of their symptoms. After an average follow-up period of 27 months (range, 1-51 months), recurrence of aqueductal obstruction has not been observed. In 1 patient, there was a complication of transient oculomotor paralysis after aqueduct stent placement. A stent migration was observed in 1 patient after remaining stable for 4 years., Conclusions: Aqueduct stent placement is technically feasible and can be useful in selected patients either with endoscopy or open surgery., (Copyright © 2015 Elsevier Inc. All rights reserved.)

Background: Entrapped fourth ventricle is the result of both inlet aqueduct and outlet fourth ventricular midline and lateral foraminae obstruction. It occurs as a sequalae of intracranial hemorrhagic or inflammatory disease condition. Usually it presents after previous shunting for communicating hydrocephalus with a period of improvement, after which manifestations of posterior fossa expanding process appear. The diagnosis of this rare condition is easy considering the patient past history and the recent clinical state, together with the midline CSF density of the dilated fourth ventricle in either the CT or MR images. The treatment options for this condition include open and endoscopic approaches together with the traditional ventricular to extracranial CSF diversionary procedures., Objective: The aim of the study was to adopt a procedure for treatment of entrapped fourth ventricle that carries the advantage of the minimally invasive technique thus avoiding the complications of the traditional opened and shunt surgeries as well as decreasing multiple procedures due to aqueduct restenosis or stent fall., Methods: Thirteen patients with symptomatic entrapped fourth ventricle underwent suboccipital endoscopic trans-fourth ventricular aqueductoplasty from May 2007 till November 2011. The Gabb endoscopic system was used and aqueductoplasty was performed using 3F Fogarty balloon followed by stent placement. Nine patients were females. The mean age was 3.6 years and the mean follow up period was 23 months. All cases had a previous one or two supratentorial VP shunt placement., Results: Short stent was used in eight patients. During the follow up, stent migration occurred in five of them. Three of these five patients developed posterior fossa compression manifestations due to aqueduct restenosis. Long stent from the aqueduct till the bur hole site for these three patients and the following five patients was used. All cases showed both clinical and radiologic improvement. Apart from the stent migration, no procedure-related complications were encountered., Conclusion: Endoscopic suboccipital paramedian aqueductoplasty with the use of a stent is a safe and effective surgical option that-in our opinion-should stand as the first line treatment for the entrapped fourth ventricle. Long stent is better used after aqueductoplasty to avoid the restenosis if no stent is used or stent fall after short stents. However, good case selection, familiarity with this fairly common endoscopic approach and longer follow-up is needed for obtaining an optimal result.

Objective: This paper discusses indications for and the technique of endoscopic aqueductoplasty with stenting., Methods: We review and summarize the clinical experience with endoscopic aqueductoplasty gained over the last 15 years on pediatric and adult patients., Results: Endoscopic aqueductoplasty with stenting presents a safe procedure. In well selected patients, it provides a long-term, stable clinical course. Aqueductoplasty alone has a high reclosure rate and should be avoided., Conclusions: Aqueductoplasty with stenting is the procedure of choice for the treatment of isolated fourth ventricle. Membranous and tumor-related aqueductal stenosis should be treated by endoscopic third ventriculostomy., (Copyright © 2013 Elsevier Inc. All rights reserved.)

Objective: Endoscopic aqueductoplasty and stenting are a preferred treatment for isolated fourth ventricle syndrome related to membranous aqueductal obstruction. We describe a technique using a small-caliber flexible endoscope that may address some limitations of current strategies., Clinical Presentation: A 39-year-old woman with hydrocephalus caused by neurococcidiomycosis and a functional right frontal ventriculoperitoneal shunt presented with vomiting and an isolated fourth ventricle. Magnetic resonance imaging showed an enlarged fourth ventricle and exuberant basilar arachnoiditis obstructing the outlet foramina of the fourth ventricle. Ventriculography indicated aqueductal obstruction., Intervention: Aqueductoplasty was planned to allow spinal fluid to flow from the fourth ventricle to the ventriculoperitoneal shunt. A stent-endoscope construct was prepared by feeding a flexible endoscope through a ventricular catheter cut 4 cm from the tip. The flexible endoscope was contoured to fit the anatomy of the aqueduct. Uncomplicated aqueductoplasty was performed through a single left frontal burr hole using the stent-endoscope construct to perforate a membranous veil and inspect the fourth ventricle. The stent was deployed over the endoscope using the proximal end of the catheter to deliver and secure the stent as the endoscope was withdrawn., Conclusion: Aqueductoplasty and stenting using a small-caliber flexible endoscope is feasible. The endoscope can be contoured to suit the anatomy of the aqueduct and improves visualization of the leading edge of the stent during deployment. Furthermore, when the endoscope is used to create the perforation, the target is not obscured by the shaft of the device used to make the perforation.

Objective: Endoscopic aqueductoplasty (EA) was considered as a good alternative to endoscopic third ventriculostomy (ETV) in selected patients. A personal experience on EA is presented in this paper., Materials and Methods: Forty-five patients with primary or secondary aqueductal stenosis underwent EA with or without a stent between June 2000 and June 2005. Age, gender, diagnosis, endoscopic procedures, complications, and outcome were reviewed. EA was considered successful when patients with noncommunicating hydrocephalus became shunt-free. When the patient did not need a fourth ventricular shunt after the EA with or without a stent, it was considered to be successful in patients with isolated fourth ventricle., Results: Fifteen patients were older than 18 years of age. EA, EA with stent, EA with ETV, and EA with stent in addition to ETV were performed in 11, 6, 11, and 17 patients, respectively. Out of 45 patients who had undergone EA with or without stent and ETV, 31 (69%) benefited from the endoscopic procedures. The type of the endoscopic procedure, diagnosis, and the age of the patients did not significantly affect the outcome., Conclusion: EA with a stent can be performed in patients with isolated fourth ventricle and in patients with aqueduct stenosis in which ETV is not feasible. EA can be dangerous and useless in aqueduct stenosis (AS), and EA with ETV is even more useless. Those patients who have undergone EA should be closely followed up for a long period of time because restenosis of the aqueduct and stent migration may happen years after endoscopic surgery.

The authors report on three consecutive cases of periaqueductal cysts, causing non-communicating hydrocephalus, successfully treated with endoscopic fenestration and aqueductal stenting. Navigation and cyst fenestration were accomplished using a slim (1.1 mm outside diameter) optic fiberscope inserted via a pre-coronal-paramedian burr hole. Third ventriculostomy was also performed after cyst fenestration in two cases. Because of the lack of data regarding such lesions and the possible recurrence with simple fenestration, an aqueductal stent connected to a subcutaneous reservoir was placed, in all 3 cases, under direct visualization. Average duration of the procedure was less than sixty minutes and there were no intra- or perioperative complications. All patients recovered clinically and their postoperative neuroimaging assessment confirmed a decrease in size of both the ventricular system and cyst (mean follow-up: 6.8 months). The authors conclude than this minimally invasive procedure is a promising, safe and effective method to treat cerebral symptomatic periaqueductal cysts and associated non-communicating hydrocephalus.

Objective: We report three patients with symptomatic isolated fourth ventricle after ventriculoperitoneal shunt placement for hydrocephalus associated with ventricular hemorrhage. All three patients were treated successfully with our new method of endoscopic aqueductal stenting under navigating system guidance., Methods: A therapeutic rigid endoscope was inserted through the thin cerebellar hemisphere, and endoscopic aqueductal stenting was performed via the enlarged fourth ventricle under navigating system guidance., Results: All three patients underwent successful procedures with good outcomes., Conclusion: Our method of aqueductal stenting is a reasonable choice for initial treatment of patients with isolated fourth ventricle, and it entails less invasive neurosurgery.

Objective: There are different approaches for the treatment of isolated fourth ventricle in children, including a suboccipital ventriculoperitoneal shunt, suboccipital craniotomy with microsurgical fenestration, and endoscopic fenestration. We discuss the indications, surgical methods, and outcome of 18 patients who underwent endoscopic treatment for isolated fourth ventricle., Methods: We retrospectively reviewed the medical histories of 18 patients with an isolated fourth ventricle. Surgical procedures included endoscopic aqueductoplasty, endoscopic aqueductoplasty with a stent, endoscopic interventriculostomy (lateral ventricle or third ventricle to fourth ventricle), and endoscopic interventriculostomy with a stent. Operations were performed between July 1997 and June 2002. The mean age of the patients at the time of surgery was 3 years. The mean follow-up was 29 months. All patients had a supratentorial ventriculoperitoneal shunt., Results: Clinical symptoms (impairment of consciousness, tetraparesis, and ataxia) improved in all patients. Reduction of the size of the fourth ventricle was observed in all patients. Seven patients required reoperation because of restenosis (39% revision rate). Restenosis occurred between 2 weeks and 7 months after surgery (average, 3 mo). Four patients underwent reoperation with stent placement, and three patients underwent reaqueductoplasty. We had the following complications: one infection, one asymptomatic subdural hygroma, one transient oculomotor paresis, and one permanent oculomotor paresis (4 [22%] of 18 patients)., Conclusion: The significant failure rate of fourth ventricle shunts has led to the development of alternative treatment methods. Endoscopic aqueductoplasty or interventriculostomy presents an effective, minimally invasive, and safe procedure for the treatment of isolated fourth ventricle in pediatric patients. Compared with suboccipital craniotomy and microsurgical fenestration, endoscopic aqueductoplasty is less invasive, and compared with fourth ventricle shunts, it is more reliable and effective.

Objective: The aim of this study is to evaluate if the long-term interventricular communication following aqueductoplasty is determined by the etiology of the aqueductal stenosis (AS)., Methods: We retrospectively analyzed 27 patients who underwent endoscopic aqueductoplasty or endoscopic interventriculostomy with or without a stent for the treatment of AS or isolated fourth ventricle. Surgeries were performed between July 1997 and June 2003. Mean age at the time of surgery was 8 years. Mean follow-up is 24 months., Results: We divided the patients into three groups. Group 1 consisted of 5 patients with membranous distal AS. Four patients were sufficiently treated by aqueductoplasty alone and 1 asymptomatic restenosis occurred. Group 2 consisted of 4 patients with AS due to a periaqueductal tumor. Three patients underwent aqueductoplasty and tumor biopsy with subsequent restenosis of the aqueduct. One patient underwent aqueductoplasty with a stent and tumor biopsy at the same time. Group 3 consisted of 18 patients with isolated fourth ventricle. The initial surgery was successful in 11 patients. Seven patients required revisions., Conclusion: The long-term communication following aqueductoplasty is determined by the etiology and morphology of the AS. In patients with a membranous distal AS aqueductoplasty alone will suffice. In patients with tumor-associated AS aqueductoplasty alone will not stay open. Those patients would better be treated with third ventriculostomy. In patients with isolated fourth ventricle the risk of restenosis is high. Therefore, we favor primary stent placement.

Objective and Importance: Dandy-Walker malformation has conventionally been managed with placement of cystoperitoneal or ventriculoperitoneal shunts. However, associated aqueductal obstruction requires simultaneous drainage of both the supratentorial and infratentorial compartments., Clinical Presentation: Three children with Dandy-Walker malformation and aqueductal obstruction were managed with endoscopic third ventriculostomy and placement of a stent from the third ventricle to the posterior fossa cyst., Intervention: After an endoscopic third ventriculostomy was performed, the stent was placed from the third ventricle to the posterior fossa cyst through the thinnest part of the posteroinferior wall of the aqueduct. There was no operative morbidity. In one patient, the stent was malpositioned, requiring a repositioning. The endoscopic third ventriculostomy was successful in two patients, whereas it failed in one, requiring a ventriculoperitoneal shunt placement., Conclusion: Cystoventricular stent placement with endoscopic third ventriculostomy is a promising alternative in patients with Dandy-Walker malformation with aqueductal obstruction.

Background: Tectal region tumors can lead to hydrocephalus secondary to aqueductal compression. Surgical options for these patients include extracranial cerebrospinal fluid (CSF) shunts, third ventriculostomy, and/or aqueductal plasty. In cases of third ventriculostomy failure, the accepted alternative is an extracranial CSF shunt. We report a patient in whom a repeat third ventriculostomy with aqueductal plasty and stenting was successful after a failed initial third ventriculostomy., Case Presentation: A 12-year-old patient with hydrocephalus secondary to a tectal tumor presented with headaches and blurry vision. She had no focal neurologic findings. She underwent a third ventriculostomy. Five months after the procedure she had recurrence of her symptoms. Therefore, she underwent a secondary third ventriculostomy with aqueductal plasty and stenting. She has been symptom-free for 1 year., Conclusion: Aqueductal plasty with stenting may be an alternative to CSF shunts in some patients with hydrocephalus because of aqueductal compression resulting from tectal tumors.

Isolated fourth ventricle (IFV) is a rare complication in patients who undergo shunt placement, and it is not easily corrected by surgical procedures. The authors report a case of IFV that was successfully treated with an aqueductal stent placed under direct visualization by using a neuroendoscope. This 36-year-old suffered meningitis after partial resection of a brainstem pilocytic astrocytoma, and subsequently developed hydrocephalus for which a ventriculoperitoneal shunt was placed. Nine months later, the patient presented with progressive cerebellar ataxia, and magnetic resonance imaging revealed slitlike supratentorial ventricles and a markedly enlarged fourth ventricle, which were compatible with the diagnosis of IFV. The surgical procedure described was performed under visualization through a styletlike slim optic fiberscope inserted into a ventricular catheter. The catheter, with the endoscope inside it, was passed through the foramen of Monro and then through the aqueduct to reach the enlarged fourth ventricle, where membranous occlusion of the foramen of Magendie was clearly visualized. The tip of the catheter was placed in the fastigium of the fourth ventricle. After the procedure, the size of the fourth ventricle was reduced and the patient's symptoms improved. Thus, it is concluded that endoscopic aqueductal stent placement is a simple and safe surgical procedure for treatment of IFV.